1
|
Mariewskaya KA, Gvozdev DA, Chistov AA, Straková P, Huvarová I, Svoboda P, Kotouček J, Ivanov NM, Krasilnikov MS, Zhitlov MY, Pak AM, Mikhnovets IE, Nikitin TD, Korshun VA, Alferova VA, Mašek J, Růžek D, Eyer L, Ustinov AV. Membrane-Targeting Perylenylethynylphenols Inactivate Medically Important Coronaviruses via the Singlet Oxygen Photogeneration Mechanism. Molecules 2023; 28:6278. [PMID: 37687107 PMCID: PMC10488391 DOI: 10.3390/molecules28176278] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 08/13/2023] [Accepted: 08/24/2023] [Indexed: 09/10/2023] Open
Abstract
Perylenylethynyl derivatives have been recognized as broad-spectrum antivirals that target the lipid envelope of enveloped viruses. In this study, we present novel perylenylethynylphenols that exhibit nanomolar or submicromolar antiviral activity against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and feline infectious peritonitis virus (FIPV) in vitro. Perylenylethynylphenols incorporate into viral and cellular membranes and block the entry of the virus into the host cell. Furthermore, these compounds demonstrate an ability to generate singlet oxygen when exposed to visible light. The rate of singlet oxygen production is positively correlated with antiviral activity, confirming that the inhibition of fusion is primarily due to singlet-oxygen-induced damage to the viral envelope. The unique combination of a shape that affords affinity to the lipid bilayer and the capacity to generate singlet oxygen makes perylenylethynylphenols highly effective scaffolds against enveloped viruses. The anticoronaviral activity of perylenylethynylphenols is strictly light-dependent and disappears in the absence of daylight (under red light). Moreover, these compounds exhibit negligible cytotoxicity, highlighting their significant potential for further exploration of the precise antiviral mechanism and the broader scope and limitations of this compound class.
Collapse
Affiliation(s)
- Kseniya A. Mariewskaya
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| | - Daniil A. Gvozdev
- Department of Biology, Lomonosov Moscow State University, Leninskie Gory 1-12, 119234 Moscow, Russia;
| | - Alexey A. Chistov
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| | - Petra Straková
- Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic; (P.S.); (I.H.); (P.S.); (D.R.)
- Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 1160/31, CZ-370 05 České Budějovice, Czech Republic
- Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic
| | - Ivana Huvarová
- Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic; (P.S.); (I.H.); (P.S.); (D.R.)
| | - Pavel Svoboda
- Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic; (P.S.); (I.H.); (P.S.); (D.R.)
- Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 1160/31, CZ-370 05 České Budějovice, Czech Republic
- Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic
- Department of Pharmacology and Pharmacy, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Palackého tř. 1946/1, CZ-612 42 Brno, Czech Republic
| | - Jan Kotouček
- Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic; (J.K.); (J.M.)
| | - Nikita M. Ivanov
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| | - Maxim S. Krasilnikov
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, Russia
| | - Mikhail Y. Zhitlov
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, Russia
| | - Alexandra M. Pak
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| | - Igor E. Mikhnovets
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| | - Timofei D. Nikitin
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| | - Vladimir A. Korshun
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| | - Vera A. Alferova
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| | - Josef Mašek
- Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic; (J.K.); (J.M.)
| | - Daniel Růžek
- Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic; (P.S.); (I.H.); (P.S.); (D.R.)
- Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 1160/31, CZ-370 05 České Budějovice, Czech Republic
- Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic
| | - Luděk Eyer
- Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic; (P.S.); (I.H.); (P.S.); (D.R.)
- Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 1160/31, CZ-370 05 České Budějovice, Czech Republic
- Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic
| | - Alexey V. Ustinov
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; (K.A.M.); (A.A.C.); (N.M.I.); (M.S.K.); (M.Y.Z.); (A.M.P.); (I.E.M.); (T.D.N.); (V.A.A.); (A.V.U.)
| |
Collapse
|
2
|
Kolarikova M, Hosikova B, Dilenko H, Barton-Tomankova K, Valkova L, Bajgar R, Malina L, Kolarova H. Photodynamic therapy: Innovative approaches for antibacterial and anticancer treatments. Med Res Rev 2023. [PMID: 36757198 DOI: 10.1002/med.21935] [Citation(s) in RCA: 18] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2022] [Revised: 12/07/2022] [Accepted: 01/03/2023] [Indexed: 02/10/2023]
Abstract
Photodynamic therapy is an alternative treatment mainly for cancer but also for bacterial infections. This treatment dates back to 1900 when a German medical school graduate Oscar Raab found a photodynamic effect while doing research for his doctoral dissertation with Professor Hermann von Tappeiner. Unexpectedly, Raab revealed that the toxicity of acridine on paramecium depends on the intensity of light in his laboratory. Photodynamic therapy is therefore based on the administration of a photosensitizer with subsequent light irradiation within the absorption maxima of this substance followed by reactive oxygen species formation and finally cell death. Although this treatment is not a novelty, there is an endeavor for various modifications to the therapy. For example, selectivity and efficiency of the photosensitizer, as well as irradiation with various types of light sources are still being modified to improve final results of the photodynamic therapy. The main aim of this review is to summarize anticancer and antibacterial modifications, namely various compounds, approaches, and techniques, to enhance the effectiveness of photodynamic therapy.
Collapse
Affiliation(s)
- Marketa Kolarikova
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Barbora Hosikova
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Hanna Dilenko
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Katerina Barton-Tomankova
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Lucie Valkova
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Robert Bajgar
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Lukas Malina
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| | - Hana Kolarova
- Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
| |
Collapse
|
3
|
Bajrai LH, El-Kafrawy SA, Hassan AM, Tolah AM, Alnahas RS, Sohrab SS, Rehan M, Azhar EI. In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea. Sci Rep 2022; 12:21723. [PMID: 36522420 PMCID: PMC9754313 DOI: 10.1038/s41598-022-26157-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Accepted: 12/12/2022] [Indexed: 12/23/2022] Open
Abstract
Hypericum perforatum and Echinacea are reported to have antiviral activities against several viral infections. In this study, H. perforatum (St. John's Wort) and Echinacea were tested in vitro using Vero E6 cells for their anti-viral effects against the newly identified Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) through its infectious cycle from 0 to 48 h post infection. The hypericin of H. perforatum and the different parts (roots, seeds, aerial) of two types of Echinacea species (Echinacea purpurea and Echinacea angustifolia) were tested for their anti-viral activities to measure the inhibition of viral load using quantitative real-time polymerase chain reaction (qRT-PCR) on cell culture assay. Interestingly, the H. perforatum-Echinacea mixture (1:1 ratio) of H. perforatum and Echinacea was tested as well on SARS-CoV-2 and showed crucial anti-viral activity competing H. perforatum then Echinacea effects as anti-viral treatment. Therefore, the results H. perforatum and Echinacea species, applied in this study showed significant anti-viral and virucidal effects in the following order of potency: H. perforatum, H. perforatum-Echinacea mixture, and Echinacea on SARS-CoV-2 infectious cycle. Additionally, molecular simulation analysis of the compounds with essential proteins (Mpro and RdRp) of the SARS-CoV-2 revealed the most potent bioactive compounds such as Echinacin, Echinacoside, Cyanin, Cyanidin 3-(6''-alonylglucoside, Quercetin-3-O-glucuronide, Proanthocyanidins, Rutin, Kaempferol-3-O-rutinoside, and Quercetin-3-O-xyloside. Thus, based on the outcome of this study, it is demanding the setup of clinical trial with specific therapeutic protocol.
Collapse
Affiliation(s)
- Leena Hussein Bajrai
- Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
| | - Sherif Ali El-Kafrawy
- Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Ahmed Mohamed Hassan
- Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Ahmed Majdi Tolah
- Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Rabig, Saudi Arabia
| | - Rabie Saleh Alnahas
- Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Sayed Sartaj Sohrab
- Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Mohd Rehan
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
- King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Esam Ibraheem Azhar
- Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
| |
Collapse
|
4
|
Alahmad A, Al-Zereini WA, Hijazin TJ, Al-Madanat OY, Alghoraibi I, Al-Qaralleh O, Al-Qaraleh S, Feldhoff A, Walter JG, Scheper T. Green Synthesis of Silver Nanoparticles Using Hypericum perforatum L. Aqueous Extract with the Evaluation of Its Antibacterial Activity against Clinical and Food Pathogens. Pharmaceutics 2022; 14:pharmaceutics14051104. [PMID: 35631691 PMCID: PMC9144328 DOI: 10.3390/pharmaceutics14051104] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Revised: 05/17/2022] [Accepted: 05/19/2022] [Indexed: 02/01/2023] Open
Abstract
The rapid development of nanotechnology and its applications in medicine has provided the perfect solution against a wide range of different microbes, especially antibiotic-resistant ones. In this study, a one-step approach was used in preparing silver nanoparticles (AgNPs) by mixing silver nitrate with hot Hypericum perforatum (St. John’s wort) aqueous extract under high stirring to prevent agglomeration. The formation of silver nanoparticles was monitored by continuous measurement of the surface plasma resonance spectra (UV-VIS). The effect of St. John’s wort aqueous extract on the formation of silver nanoparticles was evaluated and fully characterized by using different physicochemical techniques. The obtained silver nanoparticles were spherical, monodisperse, face-centered cubic (fcc) crystal structures, and the size ranges between 20 to 40 nm. They were covered with a capping layer of organic compounds considered as a nano dimension protective layer that prevents agglomeration and sedimentation. AgNPs revealed antibacterial activity against both tested Gram-positive and Gram-negative bacterial strains causing the formation of 13–32 mm inhibition zones with MIC 6.25–12.5 µg/mL; Escherichia coli strains were resistant to tested AgNPs. The specific growth rate of S. aureus was significantly reduced due to tested AgNPs at concentrations ≥½ MIC. AgNPs did not affect wound migration in fibroblast cell lines compared to control. Our results highlighted the potential use of AgNPs capped with plant extracts in the pharmaceutical and food industries to control bacterial pathogens’ growth; however, further studies are required to confirm their wound healing capability and their health impact must be critically evaluated.
Collapse
Affiliation(s)
- Abdalrahim Alahmad
- Institut für Technische Chemie, Leibniz Universität Hannove, Callinstraße 5, 30167 Hannover, Germany; (J.-G.W.); (T.S.)
- Correspondence: or (A.A.); (W.A.A.-Z.); (O.Y.A.-M.); Tel.: +49-511-7622773 (A.A.); +962-3-2372380 (W.A.A.-Z. & O.Y.A.-M.)
| | - Wael A. Al-Zereini
- Department of Biological Sciences, Faculty of Scince, Mutah University, P.O. Box 7, Mutah 61710, Jordan; (T.J.H.); (O.A.-Q.)
- Correspondence: or (A.A.); (W.A.A.-Z.); (O.Y.A.-M.); Tel.: +49-511-7622773 (A.A.); +962-3-2372380 (W.A.A.-Z. & O.Y.A.-M.)
| | - Tahani J. Hijazin
- Department of Biological Sciences, Faculty of Scince, Mutah University, P.O. Box 7, Mutah 61710, Jordan; (T.J.H.); (O.A.-Q.)
| | - Osama Y. Al-Madanat
- Department of Chemistry, Faculty of Scince, Mutah University, P.O. Box 7, Mutah 61710, Jordan
- Correspondence: or (A.A.); (W.A.A.-Z.); (O.Y.A.-M.); Tel.: +49-511-7622773 (A.A.); +962-3-2372380 (W.A.A.-Z. & O.Y.A.-M.)
| | - Ibrahim Alghoraibi
- Physics Department, Faculty of Science, Damascus University, Damascus P.O. Box 30621, Syria;
| | - Omar Al-Qaralleh
- Department of Biological Sciences, Faculty of Scince, Mutah University, P.O. Box 7, Mutah 61710, Jordan; (T.J.H.); (O.A.-Q.)
| | - Samer Al-Qaraleh
- Faculty of Medicine, Mutah University, P.O. Box 7, Mutah 61710, Jordan;
| | - Armin Feldhoff
- Institut für Physikalische Chemie und Elektrochemie, Leibniz Universität Hannove, Callinstraße 3A, 30167 Hannover, Germany;
| | - Johanna-Gabriela Walter
- Institut für Technische Chemie, Leibniz Universität Hannove, Callinstraße 5, 30167 Hannover, Germany; (J.-G.W.); (T.S.)
| | - Thomas Scheper
- Institut für Technische Chemie, Leibniz Universität Hannove, Callinstraße 5, 30167 Hannover, Germany; (J.-G.W.); (T.S.)
| |
Collapse
|
5
|
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2. Pharmaceuticals (Basel) 2022; 15:ph15050530. [PMID: 35631357 PMCID: PMC9146521 DOI: 10.3390/ph15050530] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Revised: 04/15/2022] [Accepted: 04/17/2022] [Indexed: 12/11/2022] Open
Abstract
For almost two years, the COVID-19 pandemic has constituted a major challenge to human health, particularly due to the lack of efficient antivirals to be used against the virus during routine treatment interventions. Multiple treatment options have been investigated for their potential inhibitory effect on SARS-CoV-2. Natural products, such as plant extracts, may be a promising option, as they have shown an antiviral activity against other viruses in the past. Here, a quantified extract of Hypericum perforatum was tested and found to possess a potent antiviral activity against SARS-CoV-2. The antiviral potency of the extract could be attributed to the naphtodianthrones hypericin and pseudohypericin, in contrast to other tested ingredients of the plant material, which did not show any antiviral activity. Hypericum perforatum and its main active ingredient hypericin were also effective against different SARS-CoV-2 variants (Alpha, Beta, Delta, and Omicron). Concerning its mechanism of action, evidence was obtained that Hypericum perforatum and hypericin may hold a direct virus-blocking effect against SARS-CoV-2 virus particles. Taken together, the presented data clearly emphasize the promising antiviral activity of Hypericum perforatum and its active ingredients against SARS-CoV-2 infections.
Collapse
|
6
|
Perylene as a controversial antiviral scaffold. ANNUAL REPORTS IN MEDICINAL CHEMISTRY 2022. [DOI: 10.1016/bs.armc.2022.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
7
|
Alahmad A, Feldhoff A, Bigall NC, Rusch P, Scheper T, Walter JG. Hypericum perforatum L.-Mediated Green Synthesis of Silver Nanoparticles Exhibiting Antioxidant and Anticancer Activities. NANOMATERIALS 2021; 11:nano11020487. [PMID: 33673018 PMCID: PMC7918618 DOI: 10.3390/nano11020487] [Citation(s) in RCA: 41] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Revised: 02/08/2021] [Accepted: 02/09/2021] [Indexed: 12/16/2022]
Abstract
This contribution focuses on the green synthesis of silver nanoparticles (AgNPs) with a size < 100 nm for potential medical applications by using silver nitrate solution and Hypericum Perforatum L. (St John’s wort) aqueous extracts. Various synthesis methods were used and compared with regard to their yield and quality of obtained AgNPs. Monodisperse spherical nanoparticles were generated with a size of approximately 20 to 50 nm as elucidated by different techniques (SEM, TEM). XRD measurements showed that metallic silver was formed and the particles possess a face-centered cubic structure (fcc). SEM images and FTIR spectra revealed that the AgNPs are covered by a protective surface layer composed of organic components originating from the plant extract. Ultraviolet-visible spectroscopy, dynamic light scattering, and zeta potential were also measured for biologically synthesized AgNPs. A potential mechanism of reducing silver ions to silver metal and protecting it in the nanoscale form has been proposed based on the obtained results. Moreover, the AgNPs prepared in the present study have been shown to exhibit a high antioxidant activity for 2, 2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) radical cation, and super oxide anion radical and 2,2-diphenyl-1-picrylhydrazyl. Synthesized AgNPs showed high cytotoxicity by inhibiting cell viability for Hela, Hep G2, and A549 cells.
Collapse
Affiliation(s)
- Abdalrahim Alahmad
- Institut für Technische Chemie, Leibniz Universität Hannover, 30167 Lower Saxony, Germany;
- Correspondence: (A.A.); (J.-G.W.); Tel.: +49-511-762-2773 (A.A.)
| | - Armin Feldhoff
- Institut für Physikalische Chemie und Elektrochemie, Leibniz Universität Hannover, 30167 Lower Saxony, Germany; (A.F.); (N.C.B.); (P.R.)
| | - Nadja C. Bigall
- Institut für Physikalische Chemie und Elektrochemie, Leibniz Universität Hannover, 30167 Lower Saxony, Germany; (A.F.); (N.C.B.); (P.R.)
| | - Pascal Rusch
- Institut für Physikalische Chemie und Elektrochemie, Leibniz Universität Hannover, 30167 Lower Saxony, Germany; (A.F.); (N.C.B.); (P.R.)
| | - Thomas Scheper
- Institut für Technische Chemie, Leibniz Universität Hannover, 30167 Lower Saxony, Germany;
| | - Johanna-Gabriela Walter
- Institut für Technische Chemie, Leibniz Universität Hannover, 30167 Lower Saxony, Germany;
- Correspondence: (A.A.); (J.-G.W.); Tel.: +49-511-762-2773 (A.A.)
| |
Collapse
|
8
|
Alam ST, Le TAN, Park JS, Kwon HC, Kang K. Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light. Pharmaceutics 2019; 11:E641. [PMID: 31805742 PMCID: PMC6956302 DOI: 10.3390/pharmaceutics11120641] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2019] [Revised: 11/24/2019] [Accepted: 11/28/2019] [Indexed: 12/30/2022] Open
Abstract
Bacterial antibiotic resistance is an alarming global issue that requires alternative antimicrobial methods to which there is no resistance. Antimicrobial photodynamic therapy (APDT) is a well-known method to combat this problem for many pathogens, especially Gram-positive bacteria and fungi. Hypericin and orange light APDT efficiently kill Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), and the yeast Candida albicans. Although Gram-positive bacteria and many fungi are readily killed with APDT, Gram-negative bacteria are difficult to kill due to their different cell wall structures. Pseudomonas aeruginosa is one of the most important opportunistic, life-threatening Gram-negative pathogens. However, it cannot be killed successfully by hypericin and orange light APDT. P. aeruginosa is ampicillin resistant, but we hypothesized that ampicillin could still damage the cell wall, which can promote photosensitizer uptake into Gram-negative cells. Using hypericin and ampicillin cotreatment followed by orange light, a significant reduction (3.4 log) in P. aeruginosa PAO1 was achieved. P. aeruginosa PAO1 inactivation and gut permeability improvement by APDT were successfully shown in a Caenorhabditis elegans model.
Collapse
Affiliation(s)
- Seemi Tasnim Alam
- Natural Products Informatics Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology, Gangwon-do 25451, Korea; (S.T.A.); (T.A.N.L.); (J.-S.P.); (H.C.K.)
- Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Gangwon-do 25451, Korea
| | - Tram Anh Ngoc Le
- Natural Products Informatics Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology, Gangwon-do 25451, Korea; (S.T.A.); (T.A.N.L.); (J.-S.P.); (H.C.K.)
| | - Jin-Soo Park
- Natural Products Informatics Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology, Gangwon-do 25451, Korea; (S.T.A.); (T.A.N.L.); (J.-S.P.); (H.C.K.)
| | - Hak Cheol Kwon
- Natural Products Informatics Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology, Gangwon-do 25451, Korea; (S.T.A.); (T.A.N.L.); (J.-S.P.); (H.C.K.)
| | - Kyungsu Kang
- Natural Products Informatics Research Center, Gangneung Institute of Natural Products, Korea Institute of Science and Technology, Gangwon-do 25451, Korea; (S.T.A.); (T.A.N.L.); (J.-S.P.); (H.C.K.)
- Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Gangwon-do 25451, Korea
| |
Collapse
|
9
|
Wiehe A, O'Brien JM, Senge MO. Trends and targets in antiviral phototherapy. Photochem Photobiol Sci 2019; 18:2565-2612. [PMID: 31397467 DOI: 10.1039/c9pp00211a] [Citation(s) in RCA: 152] [Impact Index Per Article: 30.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Photodynamic therapy (PDT) is a well-established treatment option in the treatment of certain cancerous and pre-cancerous lesions. Though best-known for its application in tumor therapy, historically the photodynamic effect was first demonstrated against bacteria at the beginning of the 20th century. Today, in light of spreading antibiotic resistance and the rise of new infections, this photodynamic inactivation (PDI) of microbes, such as bacteria, fungi, and viruses, is gaining considerable attention. This review focuses on the PDI of viruses as an alternative treatment in antiviral therapy, but also as a means of viral decontamination, covering mainly the literature of the last decade. The PDI of viruses shares the general action mechanism of photodynamic applications: the irradiation of a dye with light and the subsequent generation of reactive oxygen species (ROS) which are the effective phototoxic agents damaging virus targets by reacting with viral nucleic acids, lipids and proteins. Interestingly, a light-independent antiviral activity has also been found for some of these dyes. This review covers the compound classes employed in the PDI of viruses and their various areas of use. In the medical area, currently two fields stand out in which the PDI of viruses has found broader application: the purification of blood products and the treatment of human papilloma virus manifestations. However, the PDI of viruses has also found interest in such diverse areas as water and surface decontamination, and biosafety.
Collapse
Affiliation(s)
- Arno Wiehe
- biolitec research GmbH, Otto-Schott-Str. 15, 07745 Jena, Germany. and Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany
| | - Jessica M O'Brien
- Medicinal Chemistry, Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, Trinity College Dublin, The University of Dublin, St. James's Hospital, Dublin 8, Ireland.
| | - Mathias O Senge
- Medicinal Chemistry, Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, Trinity College Dublin, The University of Dublin, St. James's Hospital, Dublin 8, Ireland.
| |
Collapse
|
10
|
Ahmed I, Fang Y, Lu M, Yan Q, Kamel AEHM, Hamblin MR, Dai T. Recent Patents on Light-Based Anti-Infective Approaches. RECENT PATENTS ON ANTI-INFECTIVE DRUG DISCOVERY 2018; 13:70-88. [PMID: 29119936 PMCID: PMC5938159 DOI: 10.2174/1872213x11666171108104104] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/21/2017] [Revised: 10/17/2017] [Accepted: 10/29/2017] [Indexed: 12/30/2022]
Abstract
BACKGROUND Antibiotic resistance is one of the most serious health threats to modern medicine. The lack of potent antibiotics puts us at a disadvantage in the fight against infectious diseases, especially those caused by antibiotic-resistant microbial strains. To this end, an urgent need to search for alternative antimicrobial approaches has arisen. In the last decade, light-based anti-infective therapy has made significant strides in this fight to combat antibiotic resistance among various microbial strains. This method includes utilizing antimicrobial blue light, antimicrobial photodynamic therapy, and germicidal ultraviolet irradiation, among others. Light-based therapy is advantageous over traditional antibiotics in that it eradicates microbial cells rapidly and the likelihood of light-resistance development by microbes is low. METHODS This review highlights the patents on light-based therapy that were filed approximately within the last decade and are dedicated to eradicating pathogenic microorganisms. The primary database that was used for the search was Google Patents. The searches were performed using the keywords including blue light, antimicrobial photodynamic therapy, ultraviolet irradiation, antibiotic resistance, disinfection, bacterium, fungus, and virus. RESULTS Forty-five patents were obtained in our search: 9 patents for the antimicrobial blue light approach, 21 for antimicrobial photodynamic therapy, 11 for UV irradiation, and lastly 4 for other light-based anti-infective approaches. The treatments and devices discussed in this review are interestingly enough able to be used in various different functions and settings, such as dental applications, certain eye diseases, skin and hard surface cleansing, decontamination of internal organs (e.g., the stomach), decontamination of apparel and equipment, eradication of pathogenic microorganisms from buildings and rooms, etc. Most of the devices and inventions introduce methods of destroying pathogenic bacteria and fungi without harming human cells and tissues. CONCLUSIONS Light-based antimicrobial approaches hold great promise for the future in regards to treating antibiotic-resistant infections and related diseases.
Collapse
Affiliation(s)
- Imran Ahmed
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Yanyan Fang
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Min Lu
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Quan Yan
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Department of Ophthalmology, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Ahmed El-Hussein Mohamed Kamel
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Department of Biotechnology, National Institute of Laser Enhanced Science, Cairo University, Cairo, Egypt
| | - Michael R. Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Tianhong Dai
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
11
|
Joniova J, Buriankova L, Buzova D, Miskovsky P, Jancura D. Kinetics of incorporation/redistribution of photosensitizer hypericin to/from high-density lipoproteins. Int J Pharm 2014; 475:578-84. [DOI: 10.1016/j.ijpharm.2014.09.025] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2014] [Revised: 09/12/2014] [Accepted: 09/13/2014] [Indexed: 01/11/2023]
|
12
|
Hypericins: biotechnological production from cell and organ cultures. Appl Microbiol Biotechnol 2014; 98:9187-98. [PMID: 25301586 DOI: 10.1007/s00253-014-6119-3] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2014] [Revised: 09/24/2014] [Accepted: 09/26/2014] [Indexed: 10/24/2022]
Abstract
Hypericum perforatum L. (St. John's wort), a perennial flowering plant native to Europe, is widely used as a medicinal plant and has a long history of its use in the treatment of various ailments. Currently, H. perforatum is widely used as an herbal remedy for the treatment of mild to moderate depression. Hypericins are natural napthodianthrone compounds produced from H. perforatum (St. John's wort) which are having antitumor, antiviral (i.e., against human immunodeficiency and hepatitis C virus), antineoplastic, and antidepressant properties. Currently, field-grown plant materials are generally used for the commercial production of hypericins. It has been reported that hypericin accumulation in natural plants is influenced by different ecological and environmental conditions including light intensity, nitrogen availability, temperature, seasons, and growing regions. Therefore, up to 17-fold and 13-fold differences in hypericin and pseudohypericin amounts, respectively, are reported in different phytopharmaceutical preparations. Plant cell and organ cultures are effective systems for producing natural products, and attempts were made for the production of biomass and stable concentrations of hypericins through in vitro cultures of H. perforatum. Cell, callus, shoot, plantlet, and adventitious root cultures have been established and various chemical and physical factors which influence the biomass and secondary metabolite accumulation have been investigated. Large-scale plantlet and adventitious root cultures have also been attempted in H. perforatum in bioreactors, and various strategies have been applied for the production of higher biomass and secondary products. This review describes the biotechnological approaches employed for the production of hypericins and focuses upon the challenges and future prospects.
Collapse
|
13
|
López-Chicón P, Paz-Cristobal MP, Rezusta A, Aspiroz C, Royo-Cañas M, Andres-Ciriano E, Gilaberte Y, Agut M, Nonell S. On the mechanism of Candida spp. photoinactivation by hypericin. Photochem Photobiol Sci 2012; 11:1099-107. [PMID: 22566080 DOI: 10.1039/c2pp25105a] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The photoprocesses involved in hypericin photoinactivation of three different Candida species (C. albicans, C. parapsilosis and C. krusei) have been examined. Production of singlet oxygen from the triplet state and of superoxide from both the triplet state and the semiquinone radical anion are demonstrated. Hydrogen peroxide is formed downstream of these early events. The outcome of the photodynamic treatments is dictated by the intracellular distribution of hypericin, which is different in the three species and affects the ability of hypericin to produce the different reactive oxygen species and trigger cell-death pathways. The results are in line with the previously-observed different susceptibilities of the three Candida species to hypericin photodynamic treatments.
Collapse
Affiliation(s)
- Patricia López-Chicón
- IQS School of Engineering, Universitat Ramon Llull, Via Augusta, 390, 08017 Barcelona, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Rezusta A, López-Chicón P, Paz-Cristobal MP, Alemany-Ribes M, Royo-Díez D, Agut M, Semino C, Nonell S, Revillo MJ, Aspiroz C, Gilaberte Y. In vitro fungicidal photodynamic effect of hypericin on Candida species. Photochem Photobiol 2011; 88:613-9. [PMID: 22128758 DOI: 10.1111/j.1751-1097.2011.01053.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Hypericin is a natural photosensitizer considered for the new generation of photodynamic therapy (PDT) drugs. The aim of this study was to evaluate the in vitro fungicidal effect of hypericin PDT on various Candida spp., assessing its photocytotoxicity to keratinocytes (HaCaT) and dermal fibroblasts (hNDF) to determine possible side effects. A 3 log fungicidal effect was observed at 0.5 McFarland for two Candida albicans strains, Candida parapsilosis and Candida krusei with hypericin concentrations of 0.625, 1.25, 2.5 and 40 μm, respectively, at a fluence of 18 J cm(-2) (LED lamp emitting at 602 ± 10 nm). To obtain a 6 log reduction, significantly higher hypericin concentrations and light doses were needed (C. albicans 5 μM, C. parapsilosis 320 μM and C. krusei 320 μM; light dose 37 J cm(-2)). Keratinocytes and fibroblasts can be preserved by keeping the hypericin concentration below 1 μm and the light dose below 37 J cm(-2). C. albicans appears to be suitable for treatment with hypericin PDT without significant damage to cutaneous cells.
Collapse
Affiliation(s)
- Antonio Rezusta
- IIS Aragón, Department of Microbiology, University Hospital Miguel Servet, Universidad de Zaragoza, Zaragoza, Spain
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Eriksson ESE, Eriksson LA. The Influence of Cholesterol on the Properties and Permeability of Hypericin Derivatives in Lipid Membranes. J Chem Theory Comput 2011; 7:560-74. [DOI: 10.1021/ct100528u] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
| | - Leif A. Eriksson
- School of Chemistry, National University of Ireland—Galway, Galway, Ireland
| |
Collapse
|
16
|
Roelants M, Van Cleynenbreugel B, Lerut E, Van Poppel H, de Witte PAM. Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids. Photochem Photobiol Sci 2010; 10:151-9. [PMID: 21103512 DOI: 10.1039/c0pp00109k] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Hypericin is a bright red fluorescent compound that can be used in urological medicine as a photodiagnostic to detect non-muscle-invasive bladder cancer lesions. To this end a bladder instillation fluid is prepared in which the water-insoluble hypericin is solubilized by the presence of human serum albumin (HSA) to which the compound binds. In the present study, we explored the possibility that besides acting as a passive hypericin carrier, HSA also actively contributes to the selective localization of the compound. By using multicellular spheroids prepared from normal human urothelial (NHU) cells and from different urothelial carcinoma cell (UCC) lines (T24, RT-112 and RT-4), we simulated three-dimensionally the normal urothelium and urothelial cell carcinomas present in the bladder of patients. The distribution of hypericin in these spheroids was investigated in the presence or absence of HSA. Our data show that when hypericin is solubilized by HSA, an excellent differentiation in distribution of hypericin in normal urothelial spheroids and malignant spheroids is observed, clearly suggesting a key role for albumin in the specific localization of hypericin in non-muscle-invasive bladder tumours. Furthermore, PDT results show that both the hypericin-PDT effect on tumour spheroids and the selective character of the treatment can significantly be increased by the presence of HSA. Interestingly, we also observed that the presence of HSA did not convey tumouritropic characteristics to other photosensitizers like pheophorbide a and mTHPP, implying that both the particular characteristics of the photosensitizer and HSA contribute to the final selective accumulation of the compound in tumoural tissue.
Collapse
Affiliation(s)
- Mieke Roelants
- Laboratorium voor Farmaceutische Biologie, Katholieke Universiteit Leuven, Herestraat 49, B-3000, Leuven, Belgium
| | | | | | | | | |
Collapse
|
17
|
Fadel M, Kassab K, Youssef T. Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells. Lasers Med Sci 2010; 25:675-83. [DOI: 10.1007/s10103-010-0787-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2009] [Indexed: 11/30/2022]
|
18
|
Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, Agostinis P. The Multifaceted Photocytotoxic Profile of Hypericin. Mol Pharm 2009; 6:1775-89. [DOI: 10.1021/mp900166q] [Citation(s) in RCA: 88] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Theodossis A. Theodossiou
- Institute of Physical Chemistry, NCSR Demokritos, Patriarchou Gregoriou & Neapoleos, 153 10, Aghia Paraskevi, Attiki, Greece, Centre for Cardiovascular Biology and Medicine, BHF Laboratories, 5 University Street, University College London, London WC1E 6JJ, U.K., Laboratory for Pharmaceutical Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium, and Department of Molecular Cell Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | - John S. Hothersall
- Institute of Physical Chemistry, NCSR Demokritos, Patriarchou Gregoriou & Neapoleos, 153 10, Aghia Paraskevi, Attiki, Greece, Centre for Cardiovascular Biology and Medicine, BHF Laboratories, 5 University Street, University College London, London WC1E 6JJ, U.K., Laboratory for Pharmaceutical Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium, and Department of Molecular Cell Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | - Peter A. De Witte
- Institute of Physical Chemistry, NCSR Demokritos, Patriarchou Gregoriou & Neapoleos, 153 10, Aghia Paraskevi, Attiki, Greece, Centre for Cardiovascular Biology and Medicine, BHF Laboratories, 5 University Street, University College London, London WC1E 6JJ, U.K., Laboratory for Pharmaceutical Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium, and Department of Molecular Cell Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | - Alexandros Pantos
- Institute of Physical Chemistry, NCSR Demokritos, Patriarchou Gregoriou & Neapoleos, 153 10, Aghia Paraskevi, Attiki, Greece, Centre for Cardiovascular Biology and Medicine, BHF Laboratories, 5 University Street, University College London, London WC1E 6JJ, U.K., Laboratory for Pharmaceutical Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium, and Department of Molecular Cell Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | - Patrizia Agostinis
- Institute of Physical Chemistry, NCSR Demokritos, Patriarchou Gregoriou & Neapoleos, 153 10, Aghia Paraskevi, Attiki, Greece, Centre for Cardiovascular Biology and Medicine, BHF Laboratories, 5 University Street, University College London, London WC1E 6JJ, U.K., Laboratory for Pharmaceutical Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium, and Department of Molecular Cell Biology, K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium
| |
Collapse
|
19
|
Hager B, Strauss WSL, Falk H. Cationic Hypericin Derivatives as Novel Agents with Photobactericidal Activity: Synthesis and Photodynamic Inactivation ofPropionibacterium acnes. Photochem Photobiol 2009; 85:1201-6. [DOI: 10.1111/j.1751-1097.2009.00587.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
20
|
Gbur P, Dedic R, Chorvat Jr D, Miskovsky P, Hala J, Jancura D. Time-resolved Luminescence and Singlet Oxygen Formation After Illumination of the Hypericin-Low-density Lipoprotein Complex. Photochem Photobiol 2009; 85:816-23. [DOI: 10.1111/j.1751-1097.2008.00483.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Birt DF, Widrlechner MP, Hammer KDP, Hillwig ML, Wei J, Kraus GA, Murphy PA, McCoy J, Wurtele ES, Neighbors JD, Wiemer DF, Maury WJ, Price JP. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. PHARMACEUTICAL BIOLOGY 2009; 47:774-782. [PMID: 19907671 PMCID: PMC2774925 DOI: 10.1080/13880200902988645] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
The Iowa Center for Research on Botanical Dietary Supplements seeks to optimize Echinacea, Hypericum, and Prunella botanical supplements for human-health benefit, emphasizing antiviral, anti-inflammatory and anti-pain activities. This mini-review reports on ongoing studies on Hypericum. The Center uses the genetically diverse, well-documented Hypericum populations collected and maintained at the USDA-ARS North Central Regional Plant Introduction Station (NCRPIS), and the strength of research in synthetic chemistry at Iowa State University to tap natural diversity, to help discover key constituents and interactions among constituents that impact bioactivity and toxicity. The NCRPIS has acquired more than 180 distinct populations of Hypericum, with a focus on Hypericum perforatum L. (Hypericaceae), representing about 13% of currently recognized taxa. Center chemists have developed novel synthetic pathways for key flavones, acyl phloroglucinols, hyperolactones and a tetralin that have been found in Hypericum, and these compounds are used as standards and for bioactivity studies. Both light-dependent and light-independent anti-viral activities have been identified by using bioactivity-guided fractionation of H. perforatum and a HIV-1 infection test system. Our Center has focused on light-independent activity, potentially due to novel chemicals, and polar fractions are undergoing further fractionation. Anti-inflammatory activity has been found to be light-independent, and fractionation of a flavonoid-rich extract revealed four compounds (amentoflavone, chlorogenic acid, pseudohypericin and quercetin) that interacted in the light to inhibit lipopolysaccharide-induced prostaglandin E(2) activity. The Center continues to explore novel populations of H. perforatum and related species to identify constituents and interactions of constituents that contribute to potential health benefits related to infection.
Collapse
Affiliation(s)
- Diane F Birt
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Food Science and Human Nutrition, Iowa State University, Ames, IA
- Corresponding author: Diane F Birt, Department of Food Science and Human Nutrition, Iowa State University, 215 MacKay Hall, Ames, IA 50011. Tel: (515) 294-9873. Fax: 515-294-6193.
| | - Mark P Widrlechner
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Departments of Horticulture and Agronomy, Iowa State University, Ames, IA
- US Department of Agriculture-Agricultural Research Service, North Central Regional Plant Introduction Station, Ames, IA
| | - Kimberly DP Hammer
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Food Science and Human Nutrition, Iowa State University, Ames, IA
- Interdepartmental Genetics Graduate Program, Iowa State University, Ames, IA
| | - Matthew L Hillwig
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Genetics, Development, and Cell Biology, Iowa State University, Ames, IA
| | - Jingqiang Wei
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Chemistry, Iowa State University, Ames, IA
| | - George A Kraus
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Chemistry, Iowa State University, Ames, IA
| | - Patricia A Murphy
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Food Science and Human Nutrition, Iowa State University, Ames, IA
| | - JoeAnn McCoy
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- US Department of Agriculture-Agricultural Research Service, North Central Regional Plant Introduction Station, Ames, IA
| | - Eve S Wurtele
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Genetics, Development, and Cell Biology, Iowa State University, Ames, IA
| | - Jeffrey D Neighbors
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Chemistry, University of Iowa, Iowa City, IA
| | - David F Wiemer
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Chemistry, University of Iowa, Iowa City, IA
| | - Wendy J Maury
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Microbiology, University of Iowa, Iowa City, IA
| | - Jason P Price
- The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, IA
- Department of Microbiology, University of Iowa, Iowa City, IA
| |
Collapse
|
22
|
|
23
|
Mukherjee P, Adhikary R, Halder M, Petrich JW, Miskovsky P. Accumulation and interaction of hypericin in low-density lipoprotein--a photophysical study. Photochem Photobiol 2008; 84:706-12. [PMID: 18435618 DOI: 10.1111/j.1751-1097.2007.00234.x] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The accumulation and interaction of hypericin with the biologically important macromolecule, low-density lipoprotein (LDL), is investigated using various steady-state and time-resolved fluorescence measurements. It is concluded that multiple hypericins can penetrate considerably deeply into the LDL molecule. Up to approximately 20 nonaggregated hypericin molecules can enter LDL; but upon increasing the hypericin concentration, the fluorescence lifetime of hypericin decreases drastically, suggesting most likely the self-quenching of aggregated hypericin. There is also evidence of energy transfer from tryptophans of the constituent protein, apoB-100, to hypericin in LDL. The results demonstrate the ability of LDL to solubilize hypericin (a known photosensitizer) in nonaggregated form, which has implications for the construction of drug delivery systems.
Collapse
|
24
|
Huygens A, Crnolatac I, Develter J, Van Cleynenbreugel B, Van der Kwast T, de Witte PA. Differential Accumulation of Hypericin in Spheroids Composed of T-24 Transitional Cell Carcinoma Cells Expressing Different Levels of E-Cadherin. J Urol 2008; 179:2014-9. [DOI: 10.1016/j.juro.2007.12.038] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2007] [Indexed: 11/15/2022]
Affiliation(s)
- Ann Huygens
- Laboratorium voor Farmaceutische Biologie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Leuven, Belgium
| | - Ivo Crnolatac
- Laboratorium voor Farmaceutische Biologie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Leuven, Belgium
| | - Jan Develter
- Laboratorium voor Farmaceutische Biologie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Leuven, Belgium
| | | | - Theo Van der Kwast
- Dienst Pathologie, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands
| | - Peter A.M. de Witte
- Laboratorium voor Farmaceutische Biologie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Leuven, Belgium
| |
Collapse
|
25
|
Kascakova S, Nadova Z, Mateasik A, Mikes J, Huntosova V, Refregiers M, Sureau F, Maurizot JC, Miskovsky P, Jancura D. High level of low-density lipoprotein receptors enhance hypericin uptake by U-87 MG cells in the presence of LDL. Photochem Photobiol 2008; 84:120-7. [PMID: 18173711 DOI: 10.1111/j.1751-1097.2007.00207.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
The dependence of the uptake of hypericin (Hyp) by human glioma U-87 MG cells on the level of expression of low-density lipoprotein (LDL) receptors has been studied in this work. A special role of the LDL receptor-pathway for Hyp delivery to U-87 MG cells in the presence of LDL was revealed by the substantial increase of Hyp uptake in the situation, when the number of LDL receptors on the cell surface was elevated. Moreover, the colocalization experiments showed the lysosomal localization of Hyp following the uptake and that the concentration of Hyp in these organelles was enhanced in the cells with elevated number of LDL receptors when the incubation medium contained LDL. Both these findings suggest that LDL and LDL receptor-pathway play an important role in the delivery and accumulation of Hyp into the cells.
Collapse
Affiliation(s)
- Slavka Kascakova
- Department of Biophysics, P. J. Safarik University, Kosice, Slovakia
| | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Fonge H, Van de Putte M, Huyghe D, Bormans G, Ni Y, de Witte P, Verbruggen A. Evaluation of tumor affinity of mono-[(123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in a mouse model with a RIF-1 tumor. CONTRAST MEDIA & MOLECULAR IMAGING 2008; 2:113-9. [PMID: 17546702 DOI: 10.1002/cmmi.136] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
In this study we have compared the tumour-seeking properties of mono-[(123)I]iodoprotohypericin and mono-[(123)I]iodohypericin in C3H mice with a subcutaneous radiation-induced fibrosarcoma-1 tumor. After intravenous injection, both tracers were rapidly cleared from all organs and were retained by the tumors. There was no significant difference in tumor uptake of the two tracers at all studied time points (p > 0.05). To study the plausible mechanism of hypericin and mono-iodohypericin uptake in tumor, their plasma binding profile was investigated. Both agents show high affinity for low-density lipoproteins and to a lesser extent high-density lipoproteins and other heavy proteins. Mono-[(123)I]iodohypericin appears to be more promising as a tumor diagnostic agent, given its faster clearance from all organs.
Collapse
Affiliation(s)
- Humphrey Fonge
- Laboratory of Radiopharmacy, Faculty of Pharmaceutical Sciences, KU Leuven, Herestraat 49, Box 821, B-3000, Leuven
| | | | | | | | | | | | | |
Collapse
|
27
|
Uzdensky AB, Iani V, Ma LW, Moan J. Photobleaching of Hypericin Bound to Human Serum Albumin, Cultured Adenocarcinoma Cells and Nude Mice Skin¶. Photochem Photobiol 2007. [DOI: 10.1562/0031-8655(2002)0760320pohbth2.0.co2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
28
|
Prince AM, Pascual D, Meruelo D, Liebes L, Mazur Y, Dubovi E, Mandel M, Lavie G. Strategies for Evaluation of Enveloped Virus Inactivation in Red Cell Concentrates Using Hypericin. Photochem Photobiol 2007. [DOI: 10.1562/0031-8655(2000)0710188sfeoev2.0.co2] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
29
|
Miskovsky P, Hritz J, Sanchez-Cortes S, Fabriciova G, Ulicny J, Chinsky L. Interaction of Hypericin with Serum Albumins: Surface-enhanced Raman Spectroscopy, Resonance Raman Spectroscopy and Molecular Modeling Study¶. Photochem Photobiol 2007. [DOI: 10.1562/0031-8655(2001)0740172iohwsa2.0.co2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
30
|
Delaey EM, Obermuëller R, Zupkó I, De Vos D, Falk H, De Witte PAM. In Vitro Study of the Photocytotoxicity of Some Hypericin Analogs on Different Cell Lines. Photochem Photobiol 2007. [DOI: 10.1562/0031-8655(2001)0740164ivsotp2.0.co2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
31
|
Kocanova S, Hornakova T, Hritz J, Jancura D, Chorvat D, Mateasik A, Ulicny J, Refregiers M, Maurizot JC, Miskovsky P. Characterization of the interaction of hypericin with protein kinase C in U-87 MG human glioma cells. Photochem Photobiol 2006; 82:720-8. [PMID: 16396605 DOI: 10.1562/2005-09-26-ra-696] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
A fluorescence imaging technique was used to monitor intracellular localization of protein kinase C (PKC) in U-87 MG human glioma cells in the presence of hypericin (Hyp) and phorbol 12-myristate-13-acetate (PMA). It is shown that PKC localization, which reflects its activity, is influenced by Hyp and this influence is different from that observed for PMA which acts as PKC activator. Fluorescence binding experiments were used to determine the binding constants of Hyp to several isoforms of PKC. The obtained values of K(d)s (approximately 100 nM) suggest that Hyp binds with high affinity to PKC. Finally, molecular modeling was used to compare structural models of the interaction of C1B domain of PKC (PKC isoforms alpha, delta, gamma) with Hyp and our previously published model of the (C1B domain PKCgamma)/PMA complex. The influence of Hyp on PKC translocation in U-87 MG cells in comparison with PMA, colocalization fluorescence pattern of Hyp and PKC, the higher binding affinity of Hyp to PKC in comparison with known binding constants of phorbol esters, as well as the binding mode of Hyp and PMA to the C1B domain of PKC suggested by molecular modeling, support the idea that Hyp and PMA might competitively bind to the regulatory domain of PKC.
Collapse
Affiliation(s)
- Silvia Kocanova
- Department of Biophysics, University of PJ Safarik, Kosice, Slovak Republic
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Skripchenko A, Wagner SJ, Thompson-Montgomery D, Awatefe H. Thiazole orange, a DNA-binding photosensitizer with flexible structure, can inactivate pathogens in red blood cell suspensions while maintaining red cell storage properties. Transfusion 2006; 46:213-9. [PMID: 16441597 DOI: 10.1111/j.1537-2995.2006.00703.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND Development of a robust pathogen reduction system for red cells (RBCs) utilizing photosensitive dyes has been constrained by hemolysis, usually mediated by reactive oxygen species emanating from dye free in solution as well as dye bound to the RBC membrane. The RBC binding properties of thiazole orange (TO), a flexible nucleic acid intercalating cyanine dye that predominantly acts as a photosensitizer only when bound, were assessed along with its virucidal, bactericidal, and light-induced hemolytic activities. STUDY DESIGN AND METHODS Leukodepleted 20% hematocrit RBCs suspended in Erythrosol (RAS-2) were oxygenated, inoculated with test organisms, incubated with TO, and illuminated. Control and treated samples were analyzed by appropriate assay. Identically prepared, but uncontaminated samples were phototreated, concentrated to 45% hematocrit, and assayed for potassium leakage, hemolysis, and ATP during storage. RESULTS Approximately 21 percent TO bound to RBCs. Phototreatment inactivated from 5.4 to 7.1 log(10) of 5 tested viruses and from 2.3 to greater than 7.0 log(10) of 8 tested bacteria. Phototreated RBCs exhibited only slightly increased hemolysis, moderately elevated potassium efflux, and similar levels of ATP compared to controls. CONCLUSION TO can photoinactivate several model viruses and pathogens in RBCs under conditions that produce limited hemolysis without the addition of quenchers or competitive inhibitors.
Collapse
Affiliation(s)
- Andrey Skripchenko
- American Red Cross Biomedical Services, Holland Laboratory, Blood Components Development, Rockville, Maryland 20855, USA.
| | | | | | | |
Collapse
|
33
|
Van de Putte M, Roskams T, Vandenheede JR, Agostinis P, de Witte PAM. Elucidation of the tumoritropic principle of hypericin. Br J Cancer 2005; 92:1406-13. [PMID: 15812555 PMCID: PMC2361998 DOI: 10.1038/sj.bjc.6602512] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Hypericin is a potent agent in the photodynamic therapy of cancers. To better understand its tumoritropic behaviour, we evaluated the major determinants of the accumulation and dispersion of hypericin in subcutaneously growing mouse tumours. A rapid exponential decay in tumour accumulation of hypericin as a function of tumour weight was observed for each of the six tumour models investigated, and a similar relationship was found between tumour blood flow and tumour weight. Moreover, there was a close correlation between the higher hypericin uptake in RIF-1 tumours compared to R1 tumours and tumour vessel permeability. To define the role of lipoproteins in the transport of hypericin through the interstitial space, we performed a visual and quantitative analysis of the colocalization of hypericin and DiOC18-labelled lipoproteins in microscopic fluorescent overlay images. A coupled dynamic behaviour was found early after injection (normalised fluorescence intensity differences were on the whole less than 10%), while a shifted pattern in localisation of hypericin and DiOC18 was seen after 24 h, suggesting that during its migration through the tumour mass, hypericin is released from the lipoprotein complex. In conclusion, we were able to show that the tumour accumulation of hypericin is critically determined by a combination of biological (blood flow, vessel permeability) and physicochemical elements (affinity for interstitial constituents).
Collapse
Affiliation(s)
- M Van de Putte
- Laboratorium voor Farmaceutische Biologie, Faculteit Farmaceutische Wetenschappen, KU Leuven, Van Evenstraat 4, B-3000 Leuven, Belgium
| | - T Roskams
- Afdeling Histochemie en Cytochemie, Faculteit Geneeskunde, KU Leuven, Belgium
| | - J R Vandenheede
- Afdeling Biochemie, Faculteit Geneeskunde, KU Leuven, Belgium
| | - P Agostinis
- Afdeling Biochemie, Faculteit Geneeskunde, KU Leuven, Belgium
| | - P A M de Witte
- Laboratorium voor Farmaceutische Biologie, Faculteit Farmaceutische Wetenschappen, KU Leuven, Van Evenstraat 4, B-3000 Leuven, Belgium
- Laboratorium voor Farmaceutische Biologie, Faculteit Farmaceutische Wetenschappen, KU Leuven, Van Evenstraat 4, B-3000 Leuven, Belgium. E-mail:
| |
Collapse
|
34
|
Huygens A, Kamuhabwa AR, de Witte PAM. Stability of different formulations and ion pairs of hypericin. Eur J Pharm Biopharm 2005; 59:461-8. [PMID: 15760726 DOI: 10.1016/j.ejpb.2004.09.014] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2004] [Revised: 09/01/2004] [Accepted: 09/01/2004] [Indexed: 10/25/2022]
Abstract
Hypericin, solubilized in an instillation fluid consisting of an aqueous buffer supplemented with 1% plasma proteins, is currently used as a clinical diagnostic tool for the detection of superficial TCC (transitional cell carcinoma) tumors. However, the development of a sterile and stable hypericin stock formulation, excluding the presence of plasma constituents, would be an important factor in a more general clinical application of the method. Therefore, we investigated the stability of several heat sterilized hypericin formulations and ion pairs. Besides sodium hypericinate (in distilled water, in phosphate buffer, in polyethyleneglycol (PEG) 400), several other hypericinate salts (potassium, lysine, TRIS or hexylamine) were investigated. As to that, the physical appearance of different hypericin concentrates stored at 4 and 37 degrees C was investigated. Besides, after dilution into cell culture medium, the ability of hypericin remaining to accumulate in tumor cells and demonstrating photocytotoxic effects upon light irradiation was assessed. These findings suggest that PEG 400 is an excellent hypericin formulation, since it maintained the stability of the compound for at least 120 d when stored at either 4 or 37 degrees C. PEG 400 therefore is a suitable vehicle for the storage of hypericin prior to preparation of the bladder instillation solution.
Collapse
Affiliation(s)
- Ann Huygens
- Laboratorium voor Farmaceutische Biologie en Fytofarmacologie, Faculteit Farmaceutische Wetenschappen, Katholieke Universiteit Leuven, Leuven, Belgium
| | | | | |
Collapse
|
35
|
Huygens A, Kamuhabwa AR, van Cleynenbreugel B, van Poppel H, Roskams T, de Witte PAM. In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder. BJU Int 2005; 95:436-41. [PMID: 15679810 DOI: 10.1111/j.1464-410x.2005.05316.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
OBJECTIVE To optimise the diagnostic and phototherapeutic efficacy of hypericin in superficial bladder cancer, by developing a bladder instillation fluid that does not depend on the presence of plasma proteins for an appropriate and reliable urothelial uptake of hypericin. MATERIALS AND METHODS Sodium hypericinate (in distilled water, in sodium phosphate buffer, or in polyethylene glycol) and several other hypericinate salts (potassium, lysine, TRIS or hexylamine) were instilled with no plasma constituents into the rat bladder. The accumulation of hypericin was assessed with fluorescence microscopy. RESULTS The diagnostic and phototherapeutic efficacy of hypericin depends on its ability to penetrate the tumour lesions sufficiently to show a fluorescent signal or elicit a photodynamic response. Several instillation fluids meet the purpose, as the urothelial accumulation of hypericin was similar to that obtained with the instillation fluid supplemented with plasma proteins, used in clinical practice. The highest concentrations of hypericin in the urothelium of the rat bladder were obtained with hypericin instillation solutions prepared with distilled water or 20% polyethylene glycol 400 in distilled water. Fluorescence microscopy showed that hypericin was selectively localized in the urothelium. Furthermore, all variables investigated (hydrophilic/lipophilic balance, pH, saline, presence of organic solvent) can dramatically influence the in vivo accumulation of hypericin. CONCLUSION An appropriate and reliable urothelial uptake of hypericin does not depend on the presence of plasma protein supplements in the bladder instillation fluid.
Collapse
Affiliation(s)
- Ann Huygens
- Laboratory Pharmaceutical Biology and Phytopharmacology, Faculty of Pharmaceutical Science, UZ Gasthuisberg, KU Leuven, Van Evenstraat 4, B-3000 Leuven, Belgium
| | | | | | | | | | | |
Collapse
|
36
|
Kascakova S, Refregiers M, Jancura D, Sureau F, Maurizot JC, Miskovsky P. Fluorescence Spectroscopic Study of Hypericin-photosensitized Oxidation of Low-density Lipoproteins. Photochem Photobiol 2005; 81:1395-403. [PMID: 15960595 DOI: 10.1562/2005-04-28-ra-503] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
By means of UV-VIS absorption and fluorescence spectroscopy, we demonstrate that the photosensitizer hypericin (Hyp) interacts nonspecifically with low-density lipoproteins (LDL), most probably with the lipid fraction of LDL. The molar ratio of monomeric Hyp binding to nonoxidized LDL and mildly oxidized LDL is 30:1. Increasing the Hyp concentration further leads to the formation of Hyp aggregates inside the LDL molecule. We also demonstrate that photoactivated Hyp oxidizes LDL in a light dose and excitation wavelength dependent manner. The level of oxidation of LDL depends on the amount of Hyp inside the LDL molecule. The maximum of the photosensitized oxidation of the LDL by Hyp is achieved for a 30:1 molar ratio, which corresponds to the maximum concentration of monomeric form of Hyp in LDL.
Collapse
Affiliation(s)
- Slavka Kascakova
- Department of Biophysics, University of P. J. Safarik, Kosice, Slovak Republic
| | | | | | | | | | | |
Collapse
|
37
|
Bray J, Brattle MK. Monoclonal Antibody Production: Minimising Virus Safety Issues. Antibodies (Basel) 2004. [DOI: 10.1007/978-1-4419-8875-1_8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
38
|
Tolonen A, Hohtola A, Jalonen J. Fast high-performance liquid chromatographic analysis of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts. PHYTOCHEMICAL ANALYSIS : PCA 2003; 14:306-309. [PMID: 14516003 DOI: 10.1002/pca.720] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Hypericum perforatum L. (St. John's Wort) has been used in modern medicine for treatments of depression and neuralgic disorders. An HPLC method with photodiode array detection for the rapid determination of the major active compounds, naphthodianthrones and phloroglucinols, has been developed. The method permits the determination of hypericin, protohypericin, pseudohypericin, protopseudohypericin, hyperforin and adhyperforin in an extract in less than 5 min. Good linearity over the range 0.5-200 microg/mL for hyperforin and 0.02-100 microg/mL for hypericin was observed. Intra-assay accuracy and precision varied from 0.1 to 17% within these ranges. Lower levels of quantitative determination were 2 microg/mL for hyperforin and 0.5 microg/mL for hypericin, while detection limits were 0.1 and 0.02 microg/mL, respectively.
Collapse
Affiliation(s)
- Ari Tolonen
- Department of Chemistry, University of Oulu, PO Box 3000, 90014 Oulu, Finland.
| | | | | |
Collapse
|
39
|
Abstract
Although reports of the photodynamic inactivation of viruses appeared in 1928, long before chemotherapeutic antiviral drugs, the first clinical trial in humans-the topical treatment of herpes genitalis-did not take place until the early 1970s. Trials were discontinued due to the transformation of healthy cells and concomitant incidence of Bowen's disease in some patients, probably due to the migration of infective sections of photodamaged viral nucleic acid. With the modern development of photodynamic therapy as a cancer treatment and the use of photosensitisers in the photodecontamination of blood products, a great deal of experience has been gained, both in the minimisation of side effects in humans and in the targeting and eradication of viruses. This suggests that the photodynamic approach to a range of virus-associated infections, lesions and cancer might now be revisited with greater success.
Collapse
Affiliation(s)
- Mark Wainwright
- Department of Colour Chemistry, Centre for Photobiology and Photodynamic Therapy, The University, LS2 9JT, Leeds, UK.
| |
Collapse
|
40
|
Uzdensky AB, Iani V, Ma LW, Moan J. Photobleaching of hypericin bound to human serum albumin, cultured adenocarcinoma cells and nude mice skin. Photochem Photobiol 2002; 76:320-8. [PMID: 12403454 DOI: 10.1562/0031-8655(2002)076<0320:pohbth>2.0.co;2] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Hypericin is a promising photosensitizer for photodynamic therapy (PDT) characterized by a high yield of singlet oxygen. Photobleaching of hypericin has been studied by means of absorption and fluorescence spectroscopy in different biological systems: in human serum albumin solution, in cultured human adenocarcinoma WiDr cells and in the skin of nude mice. Prolonged exposure to light (up to 95 min, 100 mW/cm2) of wavelength around 596 nm induced fluence-dependent photobleaching of hypericin in all studied systems. The photobleaching was not oxygen dependent, and singlet oxygen probably played no significant role. Emission bands in the spectral regions 420-560 nm and above 600 nm characterize the photoproducts formed. An emission band at 615-635 nm was observed after irradiation of cells incubated with hypericin or of mouse skin in vivo but not in albumin solution. The excitation spectrum of these products resembled that of hypericin. Hypericin appears to be more photostable than most sensitizers used in PDT, including mTHPC and Photofrin.
Collapse
Affiliation(s)
- Anatoly B Uzdensky
- Department of Biophysics, Institute for Cancer Research, Montebello, Oslo, Norway.
| | | | | | | |
Collapse
|
41
|
Affiliation(s)
- Roger Y Dodd
- American Red Cross, Holland Laboratory, Rockville, MD, USA.
| |
Collapse
|
42
|
Hritz J, Kascakova S, Ulicny J, Miskovsky P. Influence of structure of human, rat, and bovine serum albumins on binding properties of photoactive drug hypericin. Biopolymers 2002; 67:251-4. [PMID: 12012440 DOI: 10.1002/bip.10110] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Fluorescence binding measurements and molecular modeling were employed to study the interaction of hypericin (Hyp) with human (HSA), rat (RSA), and bovine (BSA) serum albumins. Fluorescence emission data show the solubility of Hyp increasing in the order BSA, HSA, and RSA. Molecular modeling was used to construct the detailed structural models of the complexes and to explain the differences in the binding properties of Hyp. It was shown that the structures of Hyp/HSA and Hyp/RSA complexes are more similar and in some aspects different from those found for the Hyp/BSA complex. The role of the amino acid sequence in the IIA subdomains of HSA, RSA, and BSA is discussed to explain the observed differences.
Collapse
Affiliation(s)
- Jozef Hritz
- Department of Biophysics, P. J. Safarik University, Jesenna 5, 041 54 Kosice, Slovak Republic
| | | | | | | |
Collapse
|
43
|
Kopelman SH, Augsburger LL. Excipient compatibility study of Hypericum perforatum extract (St. John's wort) using similarity metrics to track phytochemical profile changes. Int J Pharm 2002; 237:35-46. [PMID: 11955802 DOI: 10.1016/s0378-5173(02)00025-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The formulation of botanical dietary supplements is challenging due to their complex activity-composition relationship, as well as physical and chemical stability issues. As excipient compatibility testing is a major component of sound formulation development, the objectives of this work were: (1) explore excipient compatibility storage paradigms; (2) determine interactions between phytochemicals of interest in Saint John's Wort (SJW) with several excipients; and (3) explore the application of similarity metrics to the data. Modifications to conventional isothermal stress testing paradigms included additional storage conditions of heat and moisture (5, 50 degrees C, 5 and 0% added water), as well as more rigorous controls. Binary blends of SJW and ten commonly used excipients were prepared and neat SJW was used as control. After 3 weeks, the percentage remaining of each phytochemical was determined by HPLC. Several similarity metrics were applied to the data. Common storage paradigms were suitable for excipient compatibility testing when controls of neat material are stored under similar conditions and the percentage of phytochemicals remaining in excipient:SJW blends and neat SJW are compared. Excipient incompatibilities were determined for SJW phytochemicals of interest. Similarity metrics applied to the phytochemical profiles conveniently summarized the data. This work allows logical decisions to be made regarding the formulation of SJW.
Collapse
Affiliation(s)
- Susan H Kopelman
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 North Pine Street, Baltimore, MD 21201, USA
| | | |
Collapse
|
44
|
Agostinis P, Vantieghem A, Merlevede W, de Witte PAM. Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 2002; 34:221-41. [PMID: 11849990 DOI: 10.1016/s1357-2725(01)00126-1] [Citation(s) in RCA: 278] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Photodynamic therapy (PDT) has been described as a promising new modality for the treatment of cancer. PDT involves the combination of a photosensitizing agent (photosensitizer), which is preferentially taken up and retained by tumor cells, and visible light of a wavelength matching the absorption spectrum of the drug. Each of these factors is harmless by itself, but when combined they ultimately produce, in the presence of oxygen, cytotoxic products that cause irreversible cellular damage and tumor destruction. Hypericin, a powerful naturally occurring photosensitizer, is found in Hypericum perforatum plants, commonly known as St. John's wort. In recent years increased interest in hypericin as a potential clinical anticancer agent has arisen since several studies established its powerful in vivo and in vitro antineoplastic activity upon irradiation. Investigations of the molecular mechanisms underlying hypericin photocytotoxicity in cancer cells have revealed that this photosensitizer can induce both apoptosis and necrosis in a concentration and light dose-dependent fashion. Moreover, PDT with hypericin results in the activation of multiple pathways that can either promote or counteract the cell death program. This review focuses on the more recent advances in the use of hypericin as a photodynamic agent and discusses the current knowledge on the signaling pathways underlying its photocytotoxic action.
Collapse
Affiliation(s)
- Patrizia Agostinis
- Division of Biochemistry, Faculty of Medicine, KULeuven, Leuven, Belgium
| | | | | | | |
Collapse
|
45
|
Tolonen A, Uusitalo J, Hohtola A, Jalonen J. Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2002; 16:396-402. [PMID: 11857723 DOI: 10.1002/rcm.591] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Hypericum perforatum L. (St. John's Wort) has long been known as a medicinal plant, and has been used for the treatment of depression and neuralgic disorders. Its main active constituents are believed to be a naphthodianthrone, hypericin, and a phloroglucinol, hyperforin. A sensitive high performance liquid chromatography (HPLC)/electrospray tandem mass spectrometric method for fast simultaneous determination of six major naphthodianthrones and phloroglucinols of Hypericum perforatum extract has been developed. The method, based on multiple dissociation reaction monitoring (MRM), allows the analysis of hypericin, protohypericin, pseudohypericin, protopseudo-hypericin, hyperforin and adhyperforin from the extract in less than 5 min. Good linearity over the range 0.1-1000 ng/mL for hyperforin and 2-500 ng/mL for hypericin was observed. Intra-assay accuracy and precision varied from 2 to 19% within these ranges. Lower levels of quantitation for hyperforin were 0.5 ng/mL and 2 ng/mL for hypericin.
Collapse
Affiliation(s)
- Ari Tolonen
- Department of Chemistry, University of Oulu, P.O. Box 3000, 90014 Oulu, Finland.
| | | | | | | |
Collapse
|
46
|
Kopleman SH, Augsburger LL, NguyenPho A, Zito WS, Muller FX. Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance. AAPS PHARMSCI 2001; 3:E26. [PMID: 12049489 PMCID: PMC2751215 DOI: 10.1208/ps030426] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
OBJECTIVE The complex composition-activity relationship of botanicals such as St John's Wort (SJW) presents a major challenge to product development, manufacture, and establishment of appropriate quality and performance standards for the formulated products. As part of a larger study aimed at addressing that challenge, the goals of the present study are to (1) determine and compare the phytochemical profiles of 3 commercial SJW extracts; (2) assess the possible impact of humidity, temperature, and light on their stability; and (3) evaluate several physical properties important to the development of solid dosage forms for these extracts. METHODS An adapted analytical method was developed and validated to determine phytochemical profiles and assess their stability. The extract physical properties measured were particle size (Malvern Mastersizer), flow (Carr's compressibility index; minimum orifice diameter), hygroscopicity (method of Callahan et al), and low-pressure compression physics (method of Heda et al). RESULTS The phytochemical properties differed greatly among the extracts and were extremely sensitive to changes in storage conditions, with marked instability under conditions of elevated humidity. All extracts exhibited moderate to free-flow properties and were very hygroscopic. Compression properties varied among the extracts and differed from a common use excipient, microcrystalline cellulose. CONCLUSIONS Three commercial sources of SJW extracts exhibited different physical and chemical properties. Standardization to 1 or 2 marker compounds does not ensure chemical equivalence nor necessarily equivalent pharmacological activity. Flow and compression properties appear suitable for automatic capsule-filling machines, but hygroscopicity and the moisture sensitivity of the phytochemical profile are concerns.
Collapse
Affiliation(s)
- Susan H. Kopleman
- Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, 21201 Baltimore, MD
| | - Larry L. Augsburger
- Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, 21201 Baltimore, MD
| | - Agnes NguyenPho
- Division of Product Quality Research, Food and Drug Administration, 20891 Kensington, MD
| | - William S. Zito
- Department of Pharmaceutical Sciences, Saint John's University, 11439 Jamaica, NY
| | - Fran X. Muller
- Pharmaceutical Development, GlaxoSmithKline, 19406 King of Prussia, PA
| |
Collapse
|
47
|
Staschke KA, Colacino JM. Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection. PROGRESS IN DRUG RESEARCH. FORTSCHRITTE DER ARZNEIMITTELFORSCHUNG. PROGRES DES RECHERCHES PHARMACEUTIQUES 2001; Spec No:111-83. [PMID: 11548207 DOI: 10.1007/978-3-0348-7784-8_4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
A safe and effective vaccine for hepatitis B virus (HBV) has been available for nearly twenty years and currently campaigns to provide universal vaccination in developing countries are underway. Nevertheless, chronic HBV infection remains a leading cause of chronic hepatitis worldwide and there is a strong need for safe and effective antiviral therapies. Attempts to identify and develop antiviral agents to treat chronic HBV infection remains focused on nucleoside analogs such as 3TC (lamivudine), adefovir dipivoxil, (bis-POMPMEA), and others. However, advances in our understanding of the molecular biology of HBV and the development of new assays for HBV polymerase activity, such as the reconstitution of active HBV polymerase in vitro, should facilitate large screening efforts for non-nucleoside reverse transcriptase inhibitors. Recent advances have furthered our understanding of clinical resistance to lamivudine, have provided new approaches to treatment, and have offered new perspectives on the major challenges to the identification and development of antiviral agents for chronic HBV infection. Here, in an update to our previous review article that appeared in this series [59a], we focus on recent advances that have occurred in the areas of virus structure and replication, in vitro viral polymerase assays, cell culture systems, and animal models.
Collapse
Affiliation(s)
- K A Staschke
- Infectious Diseases Research, Lilly Research Laboratories, Indianapolis, IN, USA
| | | |
Collapse
|
48
|
Miskovsky P, Hritz J, Sanchez-Cortes S, Fabriciova G, Ulicny J, Chinsky L. Interaction of hypericin with serum albumins: surface-enhanced Raman spectroscopy, resonance Raman spectroscopy and molecular modeling study. Photochem Photobiol 2001; 74:172-83. [PMID: 11547551 DOI: 10.1562/0031-8655(2001)074<0172:iohwsa>2.0.co;2] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Surface-enhanced Raman spectroscopy, resonance Raman spectroscopy and molecular modeling were employed to study the interaction of hypericin (Hyp) with human (HSA), rat (RSA) and bovine (BSA) serum albumins. The identification of the binding site of Hyp in serum albumins as well as the structural model for Hyp/HSA complex are presented. The interactions mainly reflect: (1) a change of the strength of H bonding at the N1-H site of Trp; (2) a change of the Trp side-chain conformation; (3) a change of the hydrophobicity of the Trp environment; and (4) a formation of an H-bond between the carbonyl group of Hyp and a proton donor in HSA and RSA which leads to a protonated-like carbonyl in Hyp. Our results indicate that Hyp is rigidly bound in IIA subdomain of HSA close to Trp214 (distance 5.12 A between the centers of masses). In the model presented the carbonyl group of Hyp is hydrogen bonded to Asn458. Two other candidates for hydrogen bonds have been identified between the bay-region hydroxyl group of Hyp and the carbonyl group of the Trp214 peptidic link and between the peri-region hydroxyl group of Hyp and the Asn458 carbonyl group. It is shown that the structures of the Hyp/HSA and Hyp/RSA complexes are similar to, and in some aspects different from, those found for the Hyp/BSA complex. The role of aminoacid sequence in the IIA subdomains of HSA, RSA and BSA is discussed to explain the observed differences.
Collapse
Affiliation(s)
- P Miskovsky
- Department of Biophysics, P. J. Safarik University, Jesenna, Kosice, Slovak Republic.
| | | | | | | | | | | |
Collapse
|
49
|
Zotou A, Loukou Z. Determination of hypericin and pseudohypericin in extracts fromHypericum Perforatum L. and pharmaceutical preparations by liquid chromatography-fluorescence detection. Chromatographia 2001. [DOI: 10.1007/bf02492249] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
50
|
Delaey EM, Obermuëller R, Zupkó I, De Vos D, Falk H, de Witte PA. In vitro study of the photocytotoxicity of some hypericin analogs on different cell lines. Photochem Photobiol 2001; 74:164-71. [PMID: 11547550 DOI: 10.1562/0031-8655(2001)074<0164:ivsotp>2.0.co;2] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
In the present study, hypericin analogs with an increased hydrophilic character were synthesized. As chemical modifications alter the lipophilicity/hydrophilicity balance together with the photophysical/chemical background of the molecule the influence of these structural changes on the cellular uptake, retention and subcellular localization in HeLa cells was investigated. Besides, their photocytotoxic effects using three cell lines (HeLa, MCF-7, A431), as well as their plasma protein binding were also assessed. To assess the relative hydrophilic/lipophilic character of hypericin and analogs their retention times were determined on a reversed phase high performance liquid chromatography (C-18) column. The retention time of all the hypericin analogs was < 46 min, except for dibenzyltetramethylhypericin (118 min), while the retention time of hypericin was > 200 min (solvent system: methanol/citrate buffer 30 mM pH 7; 70/30). Hypericin, hexa-, penta- and dibenzyltetramethylhypericin displayed a potent antiproliferative effect at the nanomolar range after photosensitization (3.6 J/cm2). On the contrary, photoactivated tetrasulfonhypericin and fringelite D had no antiproliferative effect on the three cell lines, whereas hypericin polyethylene glycol showed only an intermediate cytotoxic effect on A431 cells. In dark conditions no antiproliferative effect was observed for any photosensitizer. The antiproliferative photo-effect correlated well with the intracellular accumulation as measured using HeLa cells. In general, the photocytotoxic hypericin analogs concentrated to a large extent, while the noncytotoxic compounds were not taken up by the HeLa cells. Furthermore, confocal laser microscopy revealed that all photosensitizers mainly concentrated in the perinuclear region, probably corresponding with Golgi apparatus and the endoplasmic reticulum, except for tetrasulfonhypericin which located at the plasma membrane. In addition, the plasma protein binding studies illustrated that hypericin bind extensively to the low-density lipoproteins, while the other hypericin analogs were mainly bound to heavy proteins (mostly albumin) and to a small extent to low-density lipoproteins.
Collapse
Affiliation(s)
- E M Delaey
- Laboratorium voor Farmaceutische Biologie en Fytofarmacologie, Faculteit Farmaceutische Wetenschappen, K.U. Leuven, Leuven, Belgium
| | | | | | | | | | | |
Collapse
|